151 related articles for article (PubMed ID: 22307870)
1. Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients.
El-Mesallamy HO; Hamdy NM; Sallam AA
Acta Diabetol; 2013 Oct; 50(5):679-85. PubMed ID: 22307870
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of circulating lipocalins and insulin-like growth factor axis in pancreatic cancer diagnosis.
El-Mesallamy HO; Hamdy NM; Zaghloul AS; Sallam AM
Pancreas; 2013 Jan; 42(1):149-54. PubMed ID: 22617715
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: the influence of very-low-calorie diet.
Touskova V; Trachta P; Kavalkova P; Drapalova J; Haluzikova D; Mraz M; Lacinova Z; Marek J; Haluzik M
Mol Cell Endocrinol; 2012 Sep; 361(1-2):172-8. PubMed ID: 22548717
[TBL] [Abstract][Full Text] [Related]
4. Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study.
Drogan D; Schulze MB; Boeing H; Pischon T
Am J Epidemiol; 2016 Mar; 183(6):553-60. PubMed ID: 26880678
[TBL] [Abstract][Full Text] [Related]
5. Decreased Serum IGF-1/IGFBP-3 Molar Ratio is Associated with Executive Function Behaviors in Type 2 Diabetic Patients with Mild Cognitive Impairment.
Huang R; Wang P; Han J; Xia W; Cai R; Sun H; Sun J; Wang S
J Alzheimers Dis; 2015; 47(1):85-94. PubMed ID: 26402757
[TBL] [Abstract][Full Text] [Related]
6. Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.
Clemmons DR; Sleevi M; Allan G; Sommer A
J Clin Endocrinol Metab; 2007 Jul; 92(7):2652-8. PubMed ID: 17426090
[TBL] [Abstract][Full Text] [Related]
7. [Changes in IGF-I levels and its binding proteins in diabetes mellitus and obesity].
Krsek M; Skrha J; Sucharda P; Justová V; Lacinová Z
Cas Lek Cesk; 2003; 142(4):216-9. PubMed ID: 12841123
[TBL] [Abstract][Full Text] [Related]
8. Relationship between non-enzymatic glycosylation and changes in serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in patients with type 2 diabetes mellitus.
Cortizo AM; Lee PD; Cédola NV; Jasper H; Gagliardino JJ
Acta Diabetol; 1998 Jul; 35(2):85-90. PubMed ID: 9747960
[TBL] [Abstract][Full Text] [Related]
9. The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance.
Himoto T; Tani J; Miyoshi H; Yoneyama H; Mori H; Inukai M; Masugata H; Goda F; Senda S; Haba R; Masaki T
Nutr Res; 2013 Jan; 33(1):27-33. PubMed ID: 23351407
[TBL] [Abstract][Full Text] [Related]
10. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes.
Kim MS; Lee DY
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):857-61. PubMed ID: 24825082
[TBL] [Abstract][Full Text] [Related]
11. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
Helaly GF; Hussein NG; Refai W; Ibrahim M
Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
[TBL] [Abstract][Full Text] [Related]
12. Interactions among pro-inflammatory cytokines, IGF system and thyroid function in pre-pubertal obese subjects.
Street ME; Smerieri A; Montanini L; Predieri B; Iughetti L; Valenzise M; De Luca F; Vigone M; Weber G; Maghnie M; Bernasconi S
J Biol Regul Homeost Agents; 2013; 27(1):259-66. PubMed ID: 23489706
[TBL] [Abstract][Full Text] [Related]
13. Increased 24 h mean insulin-like growth factor binding protein-3 proteolytic activity in pubertal type 1 diabetic boys.
Zachrisson I; Brismar K; Carlsson-Skwirut C; Dahlquist G; Wallensteen M; Bang P
Growth Horm IGF Res; 2000 Dec; 10(6):324-31. PubMed ID: 11161963
[TBL] [Abstract][Full Text] [Related]
14. Postprandial paradoxical IGFBP-1 response in obese patients with Type 2 diabetes.
Lehtihet M; Efendic S; Brismar K
Clin Sci (Lond); 2008 Sep; 115(5):167-74. PubMed ID: 18208402
[TBL] [Abstract][Full Text] [Related]
15. Serum insulin-like growth factor II levels in normal adolescents and those with insulin dependent diabetes mellitus.
Acerini CL; Clayton KL; Hintz R; Baker B; Watts A; Holly JM; Dunger DB
Clin Endocrinol (Oxf); 1996 Jul; 45(1):13-9. PubMed ID: 8796133
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
17. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
Jiang B; Liu DB; Zhang X; DU LL; Han CZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
[TBL] [Abstract][Full Text] [Related]
18. Inverse changes in fetal insulin-like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes.
Lindsay RS; Westgate JA; Beattie J; Pattison NS; Gamble G; Mildenhall LF; Breier BH; Johnstone FD
Clin Endocrinol (Oxf); 2007 Mar; 66(3):322-8. PubMed ID: 17302863
[TBL] [Abstract][Full Text] [Related]
19. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F
Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
[TBL] [Abstract][Full Text] [Related]
20. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF).
Brausewetter F; Jehle PM; Jung MF; Boehm BO; Brueckel J; Hombach V; Osterhues HH
Horm Metab Res; 2001 Dec; 33(12):713-20. PubMed ID: 11753756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
